SCHEMBL28277282

SCHEMBL28277282

CC(C)C(Br)c1cnc2ccccc2c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.50
BIRC5 O15392 1/20 0.41
PDGFRB P09619 3/20 0.41
PDGFRA P16234 3/20 0.41
MGAM O43451 1/20 0.41
ALDH1A1 P00352 3/20 0.40
HTR3A P46098 1/20 0.40
OGA O60502 1/20 0.39
NQO1 P15559 1/20 0.39
AKR1C3 P42330 1/20 0.39
AKR1C2 P52895 1/20 0.39
CYP2A6 P11509 1/20 0.39
KDM4E B2RXH2 1/20 0.38
GLA P06280 1/20 0.38
MAPT P10636 1/20 0.38
HPGD P15428 1/20 0.38
ACHE P22303 1/20 0.38
PIK3CD O00329 1/20 0.37
PIK3CA P42336 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29756094 0.86 CYP1A2 (0.53) CYP1A2BIRC5PDGFRBPDGFRAMGAM
SCHEMBL25085747 0.82 CYP1A2 (0.53) CYP1A2BIRC5PDGFRBPDGFRAMGAM
SCHEMBL2607479 0.82 CYP1A2 (0.57) CYP1A2BIRC5PDGFRBPDGFRAMGAM
SCHEMBL28012503 0.82 CYP1A2 (0.52) CYP1A2BIRC5PDGFRBPDGFRAMGAM
SCHEMBL20030197 0.79 CYP1A2 (0.50) CYP1A2BIRC5PDGFRBPDGFRAMGAM
SCHEMBL19688524 0.79 CYP1A2 (0.53) CYP1A2PDGFRBPDGFRAMGAMALDH1A1
SCHEMBL1253863 0.79 CYP1A2 (0.53) CYP1A2BIRC5PDGFRBPDGFRAMGAM
SCHEMBL23847796 0.79 CYP1A2 (0.53) CYP1A2BIRC5PDGFRBPDGFRAMGAM
SCHEMBL30239388 0.79 CYP1A2 (0.53) CYP1A2BIRC5PDGFRBPDGFRAMGAM
SCHEMBL23773965 0.79 CYP1A2 (0.53) CYP1A2BIRC5PDGFRBPDGFRAMGAM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106132951-B quinoline-based kinase inhibitors 百时美施贵宝公司 2019-02-12 CN disclosed